Skip to main content

Closed

NGNE: Neurogene Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-44.8%

Financially safe

Stretched

Debt / equity0.04×

Interest coverage-36919.0×

Current ratio13.08×

Neurogene Inc.

NGNENASDAQ Global Market·USD·Closed

Neurogene Inc.

NGNENASDAQ·USD·Closed

$32.89

−2.11%

$32.89

−$0.71 (2.11%)

52W Range

61thpctl

Volume

0.76×avg

Mkt Cap

519.74MUSD

P/E

-6.5TTM

Div Yield

–ann

52W Range

61thpctl

Volume

0.76×avg

Market Cap

519.74MUSD

P/E Ratio

-6.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings